FDMT Institutional Ownership & Shareholders
4D MOLECULAR THERAPEUTICS IN (FDMT) is currently held by 156 institutional investors tracked by InsiderSet, with a combined reported market value of approximately $741.70M based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026.
Ra Capital Management, L.P. is currently the largest disclosed institutional shareholder of FDMT tracked by InsiderSet, reporting ownership valued at approximately $67.16M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $60.34M, representing an estimated loss of -10.15% since the filing period.
The top 10 institutional shareholders tracked on this page collectively account for approximately 60% of the total disclosed FDMT value among the investors covered in this analysis. Major shareholders include Ra Capital Management, L.P., Blackrock, Inc., Goldman Sachs Group Inc, and several other long-term asset managers with concentrated positions in 4D MOLECULAR THERAPEUTICS IN (FDMT).
This page ranks the largest institutional FDMT shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.
Institutional Holders
156
Total Reported Value
$741.70M
Largest Holder
Ra Capital Management, L.P.
Largest Position
$67.16M
Insider Transactions (90d)
11
Latest Filing Quarter
Q2 2026
New Institutional Positions
93
Funds Exiting Positions
0
| Name | Investor/Manager | Portfolio % | Quantity | Reported Balance | Current Estimated Value | Gain/loss Since Filing | Estimated Portfolio Performance |
|---|---|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 0.58% | 5,049,779 | $67,162,061 | $60,344,859 | -$6,817,202 | -10.15% | |
| Blackrock, Inc. | 0.00% | 4,546,059 | $60,462,583 | $54,325,405 | -$6,137,178 | -10.15% | |
| Goldman Sachs Group Inc | 0.01% | 4,258,668 | $56,640,284 | $50,891,083 | -$5,749,201 | -10.15% | |
| Janus Henderson Group Plc | 0.02% | 5,247,151 | $48,868,164 | $62,703,454 | +$13,835,290 | +28.31% | |
| Novo Holdings A/S | 2.51% | 3,249,178 | $43,214,067 | $38,827,677 | -$4,386,390 | -10.15% | |
| State Street Corp | 0.00% | 2,911,109 | $38,717,750 | $34,787,753 | -$3,929,997 | -10.15% | |
| Bvf Inc/Il | 0.98% | 2,879,289 | $38,294,544 | $34,407,504 | -$3,887,040 | -10.15% | |
| T. Rowe Price Investment Management, Inc. | 0.02% | 2,511,887 | $33,409,000 | $30,017,050 | -$3,391,950 | -10.15% | |
| Adage Capital Partners Gp, L.L.C. | 0.04% | 2,249,203 | $29,914,400 | $26,877,976 | -$3,036,424 | -10.15% | |
| Trails Edge Capital Partners, Lp | 4.70% | 2,227,917 | $29,631,296 | $26,623,608 | -$3,007,688 | -10.15% | |
| Vanguard Capital Management Llc | 0.00% | 2,099,055 | $27,917,432 | $25,083,707 | -$2,833,725 | -10.15% | |
| Armistice Capital, Llc | 0.74% | 2,000,000 | $26,600,000 | $23,900,000 | -$2,700,000 | -10.15% | |
| Geode Capital Management, Llc | 0.00% | 1,128,466 | $15,012,796 | $13,485,169 | -$1,527,627 | -10.18% | |
| Bank Of America Corp | 0.00% | 1,120,674 | $14,904,964 | $13,392,054 | -$1,512,910 | -10.15% | |
| Evergreen Quality Fund Gp, Ltd. | 0.20% | 951,474 | $12,654,604 | $11,370,114 | -$1,284,490 | -10.15% | |
| Parkman Healthcare Partners Llc | 1.30% | 948,184 | $12,610,847 | $11,330,799 | -$1,280,048 | -10.15% | |
| Dimensional Fund Advisors Lp | 0.00% | 787,000 | $11,263,085 | $9,404,650 | -$1,858,435 | -16.50% | |
| Deutsche Bank Ag\ | 0.00% | 710,942 | $9,455,529 | $8,495,757 | -$959,772 | -10.15% | |
| Citadel Advisors Llc | 0.01% | 687,597 | $9,145,040 | $8,216,784 | -$928,256 | -10.15% | |
| Renaissance Technologies LLC | Jim Simons | 0.01% | 614,573 | $8,173,821 | $7,344,147 | -$829,674 | -10.15% |
| Vanguard Portfolio Management Llc | 0.00% | 579,903 | $7,712,710 | $6,929,841 | -$782,869 | -10.15% | |
| Diadema Partners Lp | 2.68% | 571,107 | $7,595,723 | $6,824,729 | -$770,994 | -10.15% | |
| Northern Trust Corp | 0.00% | 562,929 | $7,486,956 | $6,727,002 | -$759,954 | -10.15% | |
| Acuta Capital Partners, Llc | 4.71% | 507,801 | $6,753,753 | $6,068,222 | -$685,531 | -10.15% | |
| Nuveen, Llc | 0.00% | 503,071 | $6,690,844 | $6,011,698 | -$679,146 | -10.15% | |
| Morgan Stanley | 0.00% | 503,020 | $6,690,165 | $6,011,089 | -$679,076 | -10.15% | |
| Rtw Investments, Lp | 0.05% | 475,737 | $6,327,302 | $5,685,057 | -$642,245 | -10.15% | |
| Schonfeld Strategic Advisors Llc | 0.03% | 407,470 | $5,419,350 | $4,869,267 | -$550,084 | -10.15% | |
| Jpmorgan Chase & Co | 0.00% | 402,137 | $5,179,524 | $4,805,537 | -$373,987 | -7.22% | |
| Charles Schwab Investment Management Inc | 0.00% | 339,275 | $4,512,358 | $4,054,336 | -$458,022 | -10.15% | |
| Opaleye Management Inc. | 0.40% | 334,437 | $4,448,012 | $3,996,522 | -$451,490 | -10.15% | |
| Vanguard Fiduciary Trust Co | 0.00% | 276,238 | $3,673,965 | $3,301,044 | -$372,921 | -10.15% | |
| Burkehill Global Management, Lp | 0.13% | 275,000 | $3,657,500 | $3,286,250 | -$371,250 | -10.15% | |
| Ubs Group Ag | 0.00% | 256,673 | $3,413,751 | $3,067,242 | -$346,509 | -10.15% | |
| Propel Bio Management, Llc | 1.76% | 252,654 | $3,360,298 | $3,019,215 | -$341,083 | -10.15% | |
| Raymond James Financial Inc | 0.00% | 242,349 | $3,223,242 | $2,896,071 | -$327,171 | -10.15% | |
| Federated Hermes, Inc. | 0.00% | 222,416 | $2,958,132 | $2,657,871 | -$300,261 | -10.15% | |
| Arrowmark Colorado Holdings Llc | 0.11% | 202,864 | $2,698,091 | $2,424,225 | -$273,866 | -10.15% | |
| Woodline Partners Lp | 0.01% | 200,001 | $2,660,013 | $2,390,012 | -$270,001 | -10.15% | |
| Brevan Howard Capital Management Lp | 0.03% | 176,850 | $2,352,105 | $2,113,358 | -$238,748 | -10.15% | |
| Acadian Asset Management Llc | 0.00% | 163,545 | $2,172,000 | $1,954,363 | -$217,637 | -10.02% | |
| Perigon Wealth Management, Llc | 0.03% | 146,185 | $2,091,907 | $1,746,911 | -$344,996 | -16.49% | |
| Bank Of New York Mellon Corp | 0.00% | 152,337 | $2,026,079 | $1,820,427 | -$205,652 | -10.15% | |
| Invesco Ltd. | 0.00% | 150,382 | $2,000,081 | $1,797,065 | -$203,016 | -10.15% | |
| Persistent Asset Partners Ltd | 0.61% | 145,585 | $1,936,281 | $1,739,741 | -$196,540 | -10.15% | |
| Voya Investment Management Llc | 0.00% | 140,200 | $1,864,660 | $1,675,390 | -$189,270 | -10.15% | |
| Wellington Management Group Llp | 0.00% | 128,464 | $1,708,571 | $1,535,145 | -$173,426 | -10.15% | |
| Fmr Llc | 0.00% | 128,316 | $1,706,596 | $1,533,376 | -$173,220 | -10.15% | |
| American Century Companies Inc | 0.00% | 114,000 | $1,516,200 | $1,362,300 | -$153,900 | -10.15% | |
| Hussman Strategic Advisors, Inc. | 0.32% | 105,000 | $1,502,550 | $1,254,750 | -$247,800 | -16.49% |
Frequently asked questions about FDMT
Who are the largest institutional holders of FDMT?
The largest institutional holders of FDMT reported in the latest SEC Form 13F filings include Ra Capital Management, L.P., Blackrock, Inc., Goldman Sachs Group Inc, Janus Henderson Group Plc, and Novo Holdings A/S. InsiderSet ranks institutional holders by their latest reported FDMT position.
What is FDMT institutional ownership?
This page tracks FDMT positions reported by institutional investment managers through SEC Form 13F. 4D MOLECULAR THERAPEUTICS IN (FDMT) institutional ownership on InsiderSet reflects disclosed 13F holdings among the managers we analyze, not every shareholder of the stock.
How many institutions own FDMT?
InsiderSet currently tracks 156 institutional managers reporting FDMT holdings in the latest available 13F data. This count reflects institutions included in the SEC Form 13F filings analyzed by InsiderSet and should not be interpreted as the total number of FDMT shareholders.
How much FDMT stock do institutions own?
Institutional investment managers disclosed approximately $741.70M in FDMT holdings for Q2 2026. This figure is reported 13F value as of the filing period, not necessarily today's market value.
When was FDMT institutional ownership last updated?
The latest FDMT institutional ownership data on InsiderSet is based on SEC Form 13F filings for the quarter ended June 30, 2026. Form 13F filings are generally reported after the quarter ends, so the holdings shown represent the latest publicly disclosed positions rather than real-time institutional holdings.
Are institutional FDMT holdings real-time?
No. Form 13F data is not real-time. It represents positions reported by institutional investment managers as of the end of the reporting quarter. An institution may have changed its FDMT position after the reporting date.
Are institutions buying or selling FDMT?
Institutional buying and selling can be analyzed by comparing FDMT positions across consecutive 13F reporting periods. InsiderSet's FDMT Ownership Changes page shows institutions that increased, reduced, initiated, or exited positions based on reported 13F holdings. View FDMT ownership changes.
How has FDMT institutional ownership changed over time?
InsiderSet tracks FDMT institutional holdings across multiple 13F reporting periods, allowing investors to compare institutional holder counts, reported value, and reported shares over time.